Position in EDIT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,616,750
+$1,283,974 QoQ
Shares Held
498,997
+207.4% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 216 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Sep 30, 2021CallValue
$0
CallShares
0
PutValue
$2,054,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. EDIT ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in EDIT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,616,750 | 498,997 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $332,776 | 162,330 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,165,184 | 335,788 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,128,168 | 1,876,440 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $331,162 | 285,485 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,488,794 | 2,747,082 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,426,418 | 3,350,856 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,486,467 | 2,459,629 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,595,698 | 2,236,617 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,114,895 | 1,590,809 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,085,229 | 1,164,773 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,273,635 | 1,369,822 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,308,543 | 1,283,937 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,003,691 | 2,142,468 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $23,046,328 | 1,882,870 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,788,222 | 151,160 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,220,512 | 747,661 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $26,239,099 | 988,290 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,054,000 | 50,000 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $541,187 | 13,174 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,699,200 | 30,000 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $840,000 | 20,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $8,606,598 | 204,919 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,215,363 | 60,125 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $2,968,678 | 100,361 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $684,749 | 34,531 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||